These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 9571254)

  • 1. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Gillini L; Murri R; Antinori A
    Clin Infect Dis; 1999 Mar; 28(3):624-8. PubMed ID: 10194089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.
    Cinque P; Casari S; Bertelli D
    N Engl J Med; 1998 Sep; 339(12):848-9. PubMed ID: 9750081
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
    Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
    Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
    Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
    Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
    Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
    An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.
    Safdar A; Rubocki RJ; Horvath JA; Narayan KK; Waldron RL
    Clin Infect Dis; 2002 Nov; 35(10):1250-7. PubMed ID: 12410486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
    Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
    N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
    Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
    Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.
    Dworkin MS
    Curr Clin Top Infect Dis; 2002; 22():181-95. PubMed ID: 12520654
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune reconstitution inflammatory syndrome associated with progressive multifocal leukoencephalopathy in a perinatally acquired human immunodeficiency virus-infected young adult.
    Ch'ng TW; Dieudonne A
    Pediatr Infect Dis J; 2007 Nov; 26(11):1068-70. PubMed ID: 17984821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient.
    Adachi E; Koibuchi T; Imai K; Kikuchi T; Koga M; Nakamura H; Miura T; Iwamoto A; Fujii T
    Int J STD AIDS; 2012 Aug; 23(8):603-5. PubMed ID: 22930304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study.
    Huang SS; Skolasky RL; Dal Pan GJ; Royal W; McArthur JC
    J Neurovirol; 1998 Jun; 4(3):324-32. PubMed ID: 9639075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy.
    Teófilo E; Gouveia J; Brotas V; da Costa P
    AIDS; 1998 Mar; 12(4):449. PubMed ID: 9520183
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside.
    Guarino M; D'Alessandro R; Rinaldi R; Stracciari A; Pazzaglia P; Costigliola P; Marinacci G; Chiodo F; Di Giandomenico G; Cancellieri C
    AIDS; 1995 Jul; 9(7):819-20. PubMed ID: 7546435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.